Commonwealth Consolidated Regulations Commonwealth Consolidated Regulations(1) An applicant for a PPI order in relation to the export of a pharmaceutical product to an eligible importing country must lodge, with the Registrar of the Federal Court, an application that includes the following:
(a) the name and address of the applicant;
(b) the applicant's address for service in relation to the application;
(c) the name of the eligible importing country;
(d) if the pharmaceutical product is to be imported by a person on behalf of, and with the authorisation of, the eligible importing country--the name and address of that person;
(e) the name of the pharmaceutical product;
(f) the proposed use of the pharmaceutical product in the eligible importing country;
(g) the amount of the pharmaceutical product proposed to be manufactured for export;
(h) the proposed duration of the PPI compulsory licence;
(i) the identity of the patent;
(j) the name of the patentee;
(k) if the patent is an innovation patent--the date of certification of the innovation patent.
(2) For paragraph (1)(b), the address for service must be an address that is mentioned in Rules made by the Federal Court for the service of the application, as in force from time to time.
(3) The applicant must:
(a) serve a copy of the application on the patentee and any other person who claims an interest in the patent as soon as practicable after lodgement; and
(b) lodge with the Registrar notice of the date when, and the place where, he or she complied with paragraph (a).
(4) For subregulation (3), the applicant must serve the copy in accordance with Rules made by the Federal Court for the service of the application, as in force from time to time.